A Study to Evaluate Safety and Efficacy of Infliximab in Chinese Participants With Moderate to Severe Plaque-type Psoriasis
Clinical trial NCT01177800 · COMPLETED
Trial details
- NCT number
- NCT01177800
- Sponsor
- Xian-Janssen Pharmaceutical Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2010-02-01
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.